Cargando…
Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse
BACKGROUND: Our original paper, published in 1992, reported a median overall survival after first relapse in breast cancer of 26 months. The current retrospective review concentrates more specifically on patients with first systemic relapse, recognizing that subsets of patients with local recurrence...
Autores principales: | Zeichner, Simon B, Ambros, Tadeu, Zaravinos, John, Montero, Alberto J, Mahtani, Reshma L, Ahn, Eugene R, Mani, Aruna, Markward, Nathan J, Vogel, Charles L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401244/ https://www.ncbi.nlm.nih.gov/pubmed/25922577 http://dx.doi.org/10.4137/BCBCR.S23794 |
Ejemplares similares
-
Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer
por: Mahtani, Reshma L, et al.
Publicado: (2019) -
Defining Expressive Language Benchmarks for Children with Down Syndrome
por: Thurman, Angela John, et al.
Publicado: (2022) -
Benchmarking orthology methods using phylogenetic patterns defined at the base of Eukaryotes
por: Deutekom, Eva S, et al.
Publicado: (2020) -
Advances in HER2-Positive Breast Cancer: Novel Therapies and Adverse Event Management
por: Mahtani, Reshma, et al.
Publicado: (2019) -
Benchmarking survival outcomes: A funnel plot for survival data
por: Putter, Hein, et al.
Publicado: (2022)